TFO
WST icon

Tarbox Family Office’s West Pharmaceutical WST Stock Holding History

Tarbox Family Office’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5
Closed -$2K – 988
2022
Q1 		$2K Sell
5
-12
-71% -$4.7K ﹤0.01% 882
2021
Q4 		$8K Buy
17
+12
+240% +$5.17K ﹤0.01% 501
2021
Q3 		$2K Hold
5
– – ﹤0.01% 987
2021
Q2 		$2K Hold
5
– – ﹤0.01% 997
2021
Q1 		$1K Hold
5
– – ﹤0.01% 1102
2020
Q4 		$1K Buy
+5
New +$1.4K ﹤0.01% 1081
2020
Q1 		– Sell
-11
Closed -$2K – 1345
2019
Q4 		$2K Hold
11
– – ﹤0.01% 873
2019
Q3 		$2K Hold
11
– – ﹤0.01% 808
2019
Q2 		$1K Buy
+11
New +$1.3K ﹤0.01% 1040

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return